You are here: Industry Insights > biotech

News List

Anti-aging startup Juvenescence bags $46M for pipeline push fiercebiotech
January 17, 2019
Juvenescence has raised the first $46 million (€40 million) tranche of series B financing en route to an anticipated $100 million round.....
Ex-Roche, Novartis, AstraZeneca leaders appointed to biotech roles pharmaphorum
January 17, 2019
Three more big pharma R&D names have made the jump to biotech as Voyager Therapeutics, ImmunSYS and Immunocore announce they have appointed former execs from Roche, Novartis and AstraZeneca.
Uncertainty Grows for Biotech as Government, FDA Shutdown Drags On firstwordpharma
January 13, 2019
Earlier this week, FDA Commissioner Scott Gottlieb said that the agency will be diverting funds from pre-market drug reviews to post-market safety surveillance.
Toxys Appoints Four New Board Members to Accelerate Business Growth b3cnewswire
January 11, 2019
Toxys BV is a biotech company based in Leiden, The Netherlands, that provides innovative, high-fidelity in vitro toxicity screening solutions to identify carcinogenic and other hazardous properties of compounds for...
Vedanta nets $27M to move microbiome assets through the clinic fiercebiotech
January 07, 2019
Barely a month after Vedanta Biosciences collected a $12 million payment from Johnson & Johnson, the biotech raised another $27 million in its series C round.....
Celgene invests in Chinese biotech Antengene again fiercebiotech
January 04, 2019
China’s Antengene has raised another $120 million in a second-round financing, with partner Celgene contributing to the tally....
Relay adds executives to its chemistry, R&D teams as it transitions to the development stage fiercebiotech
January 02, 2019
Former Fierce 15 winner Relay Therapeutics has brought on Verastem’s Mahesh Padval, Ph.D., and Eli Lilly’s Mary Mader, Ph.D., to boost its drug discovery and development operations in oncology as it begins to transition to an R&D-stage biotech.....
Moderna’s cash juggernaut rolls on with record $604M IPO fiercebiotech
December 28, 2018
Moderna’s IPO always looked like a record breaker for biotech and came in even larger than expected at $604 million, valuing the company at an eye-watering $7.9 billion.....
Black Diamond debuts with $20M, mission to drug unexplored oncogenes fiercebiotech
December 27, 2018
Versant Ventures is unveiling Black Diamond Therapeutics, a biotech developing cancer treatments that target an “undrugged and unexplored” group of oncogenes....
4 years after mega IPO, Circassia set for small-cap exchange fiercebiotech
December 27, 2018
Four years ago, Circassia looked to have ushered in a new era for biotech IPOs on the London Stock Exchange when it raised £200 million ($252 million) to.....

Previous page 1 2 3 4 5 6 7 8 9 10 Next page